Global Challenges in Retinopathy of Prematurity Screening: Modern Solutions for Modern Times

Global Challenges in Retinopathy of Prematurity Screening: Modern Solutions for Modern Times.

It has been over 70 years1 since Terry first described a case of retrolental fibroplasia, later to be known by its modern day name: retinopathy of prematurity (ROP). Although major advances have been made in terms of understanding the pathophysiology and development of treatment plans for ROP, cost-effective screening has emerged as an important global challenge when dealing with ROP in the 21s...

the tragedy of modern man in arthur millers world

what miller wants is a theatre of heightened consciousness. he speaks of two passions in a man, the passion to "feel" and the passion "know". he belives that we can have more of the latter. he says: drama is akin to the other inventions of man in that it ought to help us know more and not merely to spend our feelings. the writing of the crucible shows us that he is trying to give more heightene...

Screening for retinopathy of prematurity.

The demise of retinopathy of prematurity (ROP) was confidently forecast in the 1950s when supplemental oxygen was identified as a causal factor. Unfortunately this did not transpire and by the mid-1960s it became all too apparent that ROP was not solely of historical interest. The purpose of this article is to consider screening for ROP working on the basis that at present this condition is not...

Modern Times

Non-ophthalmologist screening for retinopathy of prematurity.

AIM To determine if a non-ophthalmologist can accurately screen for retinopathy of prematurity (ROP) by evaluating the posterior pole blood vessels of the retina. ROP is a common ocular disorder of premature infants and may require multiple screening examinations by an ophthalmologist to allow for timely intervention. Since there is a strong correlation between posterior pole vascular abnormali...